Explore more publications!
Tech Journal of Colorado
Submit Press Release

Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 3, 2025

Your Local Site Design Launches Affordable Web Development Services for Colorado Small Businesses
November 3, 2025

Your Local Site Design Launches Affordable Web Development Services for Colorado Small Businesses

Indeterminate EIN Presswire
Journey Named in the 2025 Gartner® Cool Vendors™ in Customer Service and Support Technology
November 3, 2025

Journey Named in the 2025 Gartner® Cool Vendors™ in Customer Service and Support Technology

Indeterminate EIN Presswire
Will Bitcoin Drop Below $100K? Volatility Is Unpredictable — AG META RWA Shows You How to Hedge Risks with Real Assets
November 3, 2025

Will Bitcoin Drop Below $100K? Volatility Is Unpredictable — AG META RWA Shows You How to Hedge Risks with Real Assets

Indeterminate GlobeNewswire
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 3, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU
November 3, 2025

Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU

Indeterminate GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
November 3, 2025

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025

Indeterminate GlobeNewswire
CryptoMondays: Where Decentralized Minds Meet to Build the Future
November 3, 2025

CryptoMondays: Where Decentralized Minds Meet to Build the Future

Indeterminate GlobeNewswire
NANOBIOTIX to Participate in Investor Conferences the Week of November 10th
November 3, 2025

NANOBIOTIX to Participate in Investor Conferences the Week of November 10th

Indeterminate GlobeNewswire
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis
November 3, 2025

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

Indeterminate GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
November 3, 2025

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
November 3, 2025

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

Indeterminate GlobeNewswire
BBOT to Participate in the Jefferies Global Healthcare Conference in London
November 3, 2025

BBOT to Participate in the Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire
Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results
November 3, 2025

Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
EverQuote Announces Third Quarter 2025 Financial Results
November 3, 2025

EverQuote Announces Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
November 3, 2025

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 3, 2025

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
FibroGen to Report Third Quarter 2025 Financial Results
November 3, 2025

FibroGen to Report Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin
November 3, 2025

Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin

Indeterminate GlobeNewswire
Rapid7 Expands Partnership with Microsoft to Advance Modern Detection and Response
November 3, 2025

Rapid7 Expands Partnership with Microsoft to Advance Modern Detection and Response

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions